A total of 8,825 migrants in Libya (703 females and 8,122 males) have received either Sinopharm, AstraZeneca or Pfizer vaccines against COVID-19 by 19 February 2022, according to the International Organization for Migration.
See more:
Trending
- Ghana Assistant Coach After Loss in Benghazi: Libya Is Not an Easy Opponent and We Do Not Fear Them
- Health Ministry Continues Implementation of Pharmaceutical Factory Inspectors Training Program as Part of Plan to Qualify 300 Inspectors
- Recommendations to Develop the Medical Education System, Specialized Training, and Enhance Physician Competency in Libya
- Libyan Government Signals Possible Activation of Administrative and Financial Independence After Disruption of House of Representatives Session in Zintan
- Benghazi Medical Center denies reports of its closure next month
- Emmaus US Expands in Libya Through Pharmaceutical Distribution Partnership
- MP Souad Al-Shalli Selected as Jury Member for the 2026 “Inspiring Woman” Award in Libya
- Al-Brega: Gas carriers Derna and Al-Tahadi boost supplies as congestion begins to ease